@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms (NCT05526352)
🩺 Plain-English Summary (8th-Grade Level)
The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA). The SwissNeuroFoundation AneurysmDataBase are concerned with generating the data with which to populate this database. The purpose for populating the database are to: * Screen for and evaluate markers of risk for intracranial aneurysm formation and aneurysm rupture. Are considered as markers the following: genetics factors, microbiota, environmental factors, congenital factors (ie: cerebrovascular anatomical variants), transcriptomics signature, proteomics signature,shape characteristics, haemodynamics characteristics. * Screen for and evaluate prognostic factors of outcome regarding different management strategies including watchful observation, microsurgical treatment, endovascular treatment or any combination thereof. * Implement and evaluate patient-specific management protocols integrating all available information. * Evaluate the impact of the database and use of tools to improve care, reduce costs, support knowledge discovery and promote new industrial developments.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (2 items) and avoid the listed exclusions (3 items).
Location: University of California — San Francisco, California
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- failure of a candidate to contribute clinical data,
- refusal to provide informed consent.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (22 Sites)
- University of California — San Francisco, California
- University of Cincinnati College of Medicine — Cincinnati, Ohio
- University of Virginia — Virginia Beach, Virginia
- Montreal Neurological Institute and Hospital, McGill University — Montreal,
- Helsinki University Central Hospital — Helsinki,
- Kuopio University Hospital — Kuopio,
- ICAN — Nantes,
- Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich — Munich,
- University of Pecs — Pécs,
- Erasmus Medical Center — Rotterdam,
- University Medical Center Utrecht — Utrecht,
- Jagiellonian University Medical College — Krakow,
- Barcelona Hospital General de Cataluna — Barcelona,
- Hospital Clinic Barcelona — Barcelona,
- IMIM - Hospital del Mar — Barcelona,
- Neurochirurgie / Hôpitaux Universitaire de Genève — Geneva,
- University Hospital of Lausanne (CHUV), CoLaus Datacenter — Lausanne,
- Department of Neurosurgery, Cantonal Hospital St. Gallen — Sankt Gallen,
- Klinik Hirslanded — Zurich,
- University College London — London,
- Radcliffe Infirmary — Oxford,
- Royal Hallamshire Hospital — Sheffield,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.